Medapp

Medapp Rule of 40

The Rule of 40 of Medapp (MDA.WA) as of Nov 21, 2026 is -86.73 %. In the previous year, Rule of 40 was 54.20 % — a change of -260.02% (lower).

Rule of 40

-86.73 %

YoY

-260.02%

Last updated:

Rule of 40 of Medapp is 2025 -86.73 % . Rule of 40 of Medapp was 2024 54.20 % . It decreases by -260.02% lower compared to the previous year.

The Medapp Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
-1,606.21 PLN
Jan 1, 2019
2,523.74 PLN
Jan 1, 2020
121.87 PLN
Jan 1, 2021
154.91 PLN
Jan 1, 2022
-30.19 PLN
Jan 1, 2023
-9.10 PLN
Jan 1, 2024
54.20 PLN
Jan 1, 2025
-86.73 PLN
The Medapp Rule of 40 history
YEARRule of 40YoY
-86.73 %-260.02%
54.20 %-695.37%
-9.10 %-69.85%
-30.19 %-119.49%
154.91 %+27.11%
121.87 %-95.17%
2,523.74 %-257.12%
-1,606.21 %+242.56%
-468.89 %-87.99%
-3,904.29 %-129.76%
13,119.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medapp Stock analysis

What does Medapp do? MedApp SA generates revenue through its mobile marketing solutions in the medical field, primarily via the Carna Life software application. Carna Life functions as a telemedicine platform enabling doctors and patients to communicate, with features including data upload and download for test results, offline data review, and graphical statistics. The company serves healthcare providers and patients seeking telemedicine services, focusing on the Polish market through its Krakow headquarters. Moonrock Enterprise SA controls MedApp SA, leveraging its software for medical communication solutions. The firm's revenue model centers on the Carna Life application, which provides telemedicine services by facilitating secure data exchange between doctors and patients. Patients use the app to upload test results, while doctors interpret them through the platform, supported by offline functionality and data visualization tools. This system targets medical professionals and patients in Poland, operating within the telemedicine sector without external partnerships or additional branded products. MedApp SA's business relies solely on the Carna Life telemedicine system, which offers both online and offline modes for data management. The application includes statistics, visualizations, and tables for interpreted medical data, serving as a communication channel between healthcare providers and patients. Controlled by Moonrock Enterprise SA, the company monetizes its software through direct sales to medical institutions and patient users in the Polish healthcare market. Medapp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medapp stock

Rule of 40 of Medapp is -86.73 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Medapp since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Medapp

All Key Metrics — Medapp